Is it time to screen for multiple myeloma?
作者信息
Ghobrial Irene M, Chabrun Floris
机构信息
Dana-Farber Cancer Institute.
出版信息
Blood. 2025 Jan 16;145(3):253-255. doi: 10.1182/blood.2024027065.
Abstract
摘要
相似文献
1
Is it time to screen for multiple myeloma?是时候进行多发性骨髓瘤筛查了吗？
Blood. 2025 Jan 16;145(3):253-255. doi: 10.1182/blood.2024027065.
2
Early versus deferred treatment for early stage multiple myeloma.早期多发性骨髓瘤的早期治疗与延迟治疗
Cochrane Database Syst Rev. 2003;2003(1):CD004023. doi: 10.1002/14651858.CD004023.
3
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.多发性骨髓瘤患者接受免疫调节剂治疗时的门诊抗血栓治疗。
Cochrane Database Syst Rev. 2021 Sep 28;9(9):CD014739. doi: 10.1002/14651858.CD014739.
4
Pharmacoeconomic evaluation of carfilzomib ixazomib for the treatment of relapsed and refractory multiple myeloma.卡非佐米与伊沙佐米治疗复发难治性多发性骨髓瘤的药物经济学评价
Future Sci OA. 2025 Dec;11(1):2514969. doi: 10.1080/20565623.2025.2514969. Epub 2025 Jun 18.
5
Overall and complete response rates as potential surrogates for overall survival in relapsed/refractory multiple myeloma.总缓解率和完全缓解率作为复发/难治性多发性骨髓瘤总生存期的潜在替代指标。
Future Oncol. 2023 Feb;19(6):463-471. doi: 10.2217/fon-2022-0932. Epub 2023 Apr 21.
6
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比，自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
7
Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women.盆底肌训练用于预防和治疗产前及产后女性的尿失禁和粪失禁。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD007471. doi: 10.1002/14651858.CD007471.pub3.
8
Bortezomib for the treatment of multiple myeloma.硼替佐米用于治疗多发性骨髓瘤。
Cochrane Database Syst Rev. 2016 Apr 20;4(4):CD010816. doi: 10.1002/14651858.CD010816.pub2.
9
Minocycline for acne vulgaris: efficacy and safety.米诺环素治疗寻常痤疮：疗效与安全性。
Cochrane Database Syst Rev. 2003(1):CD002086. doi: 10.1002/14651858.CD002086.
10
Protease-modulating matrix treatments for healing venous leg ulcers.用于治疗下肢静脉溃疡愈合的蛋白酶调节基质疗法。
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD011918. doi: 10.1002/14651858.CD011918.pub2.
引用本文的文献
1
Genetic, epigenetic, and molecular determinants of multiple myeloma and precursor plasma cell disorders: a pathophysiological overview.多发性骨髓瘤和前驱浆细胞疾病的遗传、表观遗传及分子决定因素：病理生理学概述
Med Oncol. 2025 Jun 3;42(7):234. doi: 10.1007/s12032-025-02807-0.
本文引用的文献
1
Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection.通过检测方法比较意义未明的单克隆丙种球蛋白病的进展风险。
Blood. 2025 Jan 16;145(3):325-333. doi: 10.1182/blood.2024025415.
2
Prevalence of smoldering multiple myeloma based on nationwide screening.基于全国性筛查的冒烟型多发性骨髓瘤患病率。
Nat Med. 2023 Feb;29(2):467-472. doi: 10.1038/s41591-022-02183-6. Epub 2023 Feb 6.
3
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.采用质谱法对高危美国人群进行筛查后的单克隆丙种球蛋白病患病率及临床结局：一项多中心队列研究。
Lancet Haematol. 2022 May;9(5):e340-e349. doi: 10.1016/S2352-3026(22)00069-2. Epub 2022 Mar 25.
4
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM).国际骨髓瘤工作组冒烟型多发性骨髓瘤（SMM）的风险分层模型。
Blood Cancer J. 2020 Oct 16;10(10):102. doi: 10.1038/s41408-020-00366-3.
5
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.单克隆丙种球蛋白病患病率的种族差异：一项基于美国国家健康与营养检查调查中12482人的人群研究。
Leukemia. 2014 Jul;28(7):1537-42. doi: 10.1038/leu.2014.34. Epub 2014 Jan 20.
6
Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.来那度胺联合地塞米松治疗高危冒烟型多发性骨髓瘤。
N Engl J Med. 2013 Aug 1;369(5):438-47. doi: 10.1056/NEJMoa1300439.
7
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.意义未明的单克隆丙种球蛋白血症（MGUS）和冒烟型（无症状）多发性骨髓瘤：IMWG 共识观点——进展风险因素以及监测和管理指南。
Leukemia. 2010 Jun;24(6):1121-7. doi: 10.1038/leu.2010.60. Epub 2010 Apr 22.
8
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.意义未明的单克隆丙种球蛋白病（MGUS）始终先于多发性骨髓瘤：一项前瞻性研究。
Blood. 2009 May 28;113(22):5412-7. doi: 10.1182/blood-2008-12-194241. Epub 2009 Jan 29.
9
Prevalence of monoclonal gammopathy of undetermined significance.意义未明的单克隆丙种球蛋白病的患病率。
N Engl J Med. 2006 Mar 30;354(13):1362-9. doi: 10.1056/NEJMoa054494.
Zotero 插件